Dexcom (DXCM) EPS (Basic) (QoQ) (2010 - 2026)
Dexcom (DXCM) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.25 Bn | 18.84 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.81% |
| Mar 31, 2026 | -24.38% |
| Dec 31, 2025 | -5.60% |
| Sep 30, 2025 | 58.25% |
| Jun 30, 2025 | 70.15% |
| Mar 31, 2025 | -30.08% |
| Dec 31, 2024 | 12.88% |
| Sep 30, 2024 | -5.01% |
| Jun 30, 2024 | -4.19% |
| Mar 31, 2024 | -43.49% |
| Dec 31, 2023 | 112.67% |
| Sep 30, 2023 | 4.17% |
| Jun 30, 2023 | 138.48% |
| Mar 31, 2023 | -46.69% |
| Dec 31, 2022 | -9.20% |
| Sep 30, 2022 | 100.20% |
| Jun 30, 2022 | -48.18% |
| Mar 31, 2022 | 1,926.41% |
| Dec 31, 2021 | -106.08% |
| Sep 30, 2021 | 11.12% |